… The most challenging issue in RAI-refractory thyroid cancer is when a patient should be …
with small metastases from well-differentiated thyroid cancer who have high uptake of RAI in all …

… for systemic therapies. In this review article, we will discuss about the different systemic
therapeutic … In case of differentiated thyroid cancers, radio-iodine therapy is used as adjuvant …

… cytotoxic chemotherapy,[8] augmenting the need for novel therapies. This review will focus
on systemic treatments for patients with radioactive iodine–resistant thyroid cancer that has …

… of patients with thyroid cancers harboring specific alterations (… thyroid carcinoma with a
focus on the systemic therapies and targeted agents for advanced or metastatic thyroid cancers…

… local intervention such as surgery or radiotherapy may be considered for systemic therapy.
Previously, systemic therapy relied on the use of cytotoxic chemotherapy for advanced MTC …

… option for the treatment of advanced and progressive thyroid cancer. Currently, … of thyroid
cancer with regards to the advanced and progressive cases that require systemic therapies that …

… The therapeutic scenario has now been enriched with new pharmacological … systemic
therapy updates for treating patients with advanced/metastatic DTCs, anaplastic thyroid cancers (…

… of metastatic and recurrent thyroid cancer. This chapter summarizes the rationale for
using systemic therapy and the approved drugs in recurrent or metastatic thyroid carcinoma. …

… Less invasive alternatives to surgery for low-risk thyroid cancer, such as active surveillance
… New systemic therapies are now available for patients with advanced thyroid cancer. …

… Radioiodine (RAI) therapy has been one of the primary systemic therapy options for metastatic
thyroid cancer of follicular cell origin for more than 50 years. While often very effective in …